Lefenfeld Michael 4
4 · Immunome Inc. · Filed Oct 8, 2020
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Lefenfeld Michael
Director
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-10-06−22,222→ 0 total→ Common Stock (22,222 underlying) - Conversion
Common Stock
2020-10-06+22,222→ 22,222 total - Conversion
Warrant (right to buy)
2020-10-06+11,111→ 11,111 totalExercise: $9.00Exp: 2023-06-02→ Common Stock (11,111 underlying) - Conversion
Warrant (right to buy)
2020-10-06−11,111→ 0 totalExercise: $9.00Exp: 2023-06-02→ Series A Convertible Preferred Stock (11,111 underlying)
Footnotes (3)
- [F1]Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F2]Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F3]Immediately exercisable.